Open-label, single-arm, multi-center, pharmacokinetic, safety and tolerability study oflevetiracetam intravenous infusion in children (4 - 16 years old) with epilepsy.

Phase 1

• Conditions: Epilepsy; MedDRA version: 9.1Level: LLTClassification code 10015037Term: Epilepsy

• Registration Number: EUCTR2006-005722-23-FR
• Lead Sponsor: CB Pharma S.A.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-04-23
• Study Completion: 2010-02-02
• Last Update Posted: 8 October 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Secondary Objective: ;Primary end point(s): ;Main Objective: